- Mon - Fri 09:00 - 16:00
- 182-184 High Street North, East Ham, London, UK, E6 2JA
RETA 5 (GLP-1 + GIP + GCGR)
zł389.00
RETA 5 (GLP-1 + GIP + GCGR)
Reta Support Formula 5mg – Research Peptide for Laboratory Use RETA 5 mg is a high-purity research peptide inspired by Tirzepatide, a dual GLP-1/GIP receptor agonist. Designed for laboratory studies on obesity, type 2 diabetes, and metabolic regulation. For research use only by qualified personnel.
Add to cart
Buy Now
⛟ Shipping Notification:
Orders to EU we ship from Polish or German.
Orders from outside EU we ship from Great Britain.
Orders to EU we ship from Polish or German.
Orders from outside EU we ship from Great Britain.
Reta Support Formula 5mg – Advanced Research Peptide for Laboratory Use
Reta Support Formula 5mg is a high-purity research peptide designed exclusively for laboratory, modeled after Tirzepatide, a dual GLP-1 and GIP receptor agonist. This compound is intended for scientific investigations related to obesity, type 2 diabetes, and metabolic regulation.
With its dual-action mechanism targeting GLP-1 and GIP receptors, RETA 5 mg is a valuable tool for researchers exploring innovative metabolic therapies. It is of particular interest for studies on glycemic control, appetite regulation, and fat metabolism.
Applications of Reta Support Formula 5mg in Laboratory Research
Reta Support Formula 5mg mg is strictly for laboratory research and may be used in:
- Studies on obesity, metabolic syndrome, and type 2 diabetes
- Investigations into GLP-1 and GIP receptor agonist mechanisms
- Research on incretin-based peptides
- Analysis of fat and carbohydrate metabolism
Potential Research Outcomes
Studies on similar compounds suggest potential areas of exploration for RETA 5 mg, including:
- Appetite suppression mechanisms
- Glucose level regulation
- Prolonged satiety effects
- Metabolic parameter improvements
- Dual GLP-1 and GIP receptor activation
Product Specifications
- Name: RET
- Active Substance Content: 5mg
- Form: Lyophilized powder
- Purity: ≥ 98% (HPLC)
- Type: Tirzepatide-like research peptide
- Synonyms: GLP-1/GIP agonist peptide
- Category: Metabolic research peptides
⚠️ Legal and Safety Information
Reta Support Formula 5mg is classified as a chemical reagent for research purposes only, permitted for use in laboratory settings by qualified personnel within the European Union. It is not a dietary supplement, medicine, or food product and is not intended for human or animal consumption.
Why Choose Reta Support Formula 5mg for Research?
- Inspired by a leading molecule in metabolic research
- Exceptional purity (≥ 98%)
- Versatile applications in metabolic and glucose regulation studies
- Premium-grade peptide for laboratory investigations
FAQs
What is Reta?
Reta is a multi-functional peptide with proven effects that: Regulates blood sugar levels – supports healthy glucose management and improves insulin sensitivity. Supports weight loss – reduces appetite and supports calorie control. Improves metabolic health – supports the hormonal system and the body's energy balance.
How does Reta work?
Reta combines the mechanisms of activation of GLP-1, GIP and glucagon receptors, thus providing comprehensive support for the body. The action includes: Appetite control: Helps reduce the feeling of hunger and prolong the feeling of satiety. Metabolism optimization: Supports the process of burning fat tissue and energy regulation. Improved sugar management: Stabilizes blood glucose levels and supports pancreatic function.
Benefits of using Reta
Weight Loss Support: Reduced appetite. Effective fat burning. Better glycemic control: Stabilization of fasting and post-meal blood sugar levels. Increased insulin sensitivity. Improved metabolic health: Reduced risk associated with overweight and insulin resistance. Increased energy efficiency of the body. Long-term effects: Combination of use with physical activity and a healthy diet supports lasting lifestyle changes.
How to prepare Reta for use?
Add 1 ml of bacteriostatic water to the peptide vial. Mix gently to maintain the peptide structure. Store in a refrigerator at 2°C–8°C.
What's in the package?
1 vial of Reta peptide of your choice
Who is Reta for?
Reta is ideal for people: Looking for effective support in weight loss. Struggling with metabolic problems such as insulin resistance. Wanting to improve appetite control and maintain a healthy lifestyle.
Why choose Reta?
Modern formula based on retatrutide. Proven effectiveness in clinical studies. High quality and purity (>99%). Comprehensive action supporting metabolic health.
User reviews
Reta Peptide users praise its effectiveness in appetite control, weight loss and improved well-being.
Clinical Trials
The effectiveness of Reta has been confirmed in numerous clinical studies. More information can be found in medical publications: https://dietetycy.org.pl/retatrutyd-lek-otylosc/ https://www.ptdiab.pl/aktualnosci/retatrutyd-nowy-lek-w-walce-z-otyloscia
See how much you can reduce
On Reta, within 6 months you can achieve an impressive weight loss of an average of 15-35% of your initial weight, which means a loss of 15-35 kg, depending on your initial weight, lifestyle, diet and physical activity.
Additional information
The product (substance) is not intended for consumption or use as a dietary supplement. •Keep out of reach of children. •Store in a tightly closed container. •Store in a dry, cool and shaded place, away from moisture. •The product should be stored only in its original packaging. •Avoid contact with the substance during pregnancy and breastfeeding. •In the event of feeling unwell or adverse reactions after contact with the substance, consult a doctor.
Related products
-30%
-23%
-9%
Reta Support Formula 10mg (GLP-1 + GIP + GCGR)
Original price was: zł650.00.zł589.00Current price is: zł589.00.
-9%
Survo Weight Booster 12mg (GLP-1 + GCGR)
Original price was: zł1,099.00.zł999.00Current price is: zł999.00.
-14%
-23%
5 x RETA 10mg PACK – lowest price (GLP-1 + GIP + GCGR)
Original price was: zł3,099.00.zł2,399.00Current price is: zł2,399.00.
-12%
Reviews
There are no reviews yet.